Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study

Abstract

Previous studies have suggested that adherence to imatinib therapy can be an obstacle among patients with chronic myeloid leukemia (CML). We studied adherence to imatinib therapy among CML patients treated at the Sahlgrenska University Hospital. We identified all CML patients that were alive at the 1st of January 2010 (n = 70). Nineteen patients were… (More)
DOI: 10.1007/s00277-011-1359-0

4 Figures and Tables

Topics

  • Presentations referencing similar topics